BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 14616430)

  • 1. Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial.
    Pfrunder A; Schiesser M; Gerber S; Haschke M; Bitzer J; Drewe J
    Br J Clin Pharmacol; 2003 Dec; 56(6):683-90. PubMed ID: 14616430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding.
    Murphy PA; Kern SE; Stanczyk FZ; Westhoff CL
    Contraception; 2005 Jun; 71(6):402-8. PubMed ID: 15914127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction between St John's wort and an oral contraceptive.
    Hall SD; Wang Z; Huang SM; Hamman MA; Vasavada N; Adigun AQ; Hilligoss JK; Miller M; Gorski JC
    Clin Pharmacol Ther; 2003 Dec; 74(6):525-35. PubMed ID: 14663455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. St John's wort extract (Ze 117) does not alter the pharmacokinetics of a low-dose oral contraceptive.
    Will-Shahab L; Bauer S; Kunter U; Roots I; Brattström A
    Eur J Clin Pharmacol; 2009 Mar; 65(3):287-94. PubMed ID: 19015839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of St John's wort on imatinib mesylate pharmacokinetics.
    Frye RF; Fitzgerald SM; Lagattuta TF; Hruska MW; Egorin MJ
    Clin Pharmacol Ther; 2004 Oct; 76(4):323-9. PubMed ID: 15470331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of St. John's wort supplementation on the pharmacokinetics of bupropion in healthy male Chinese volunteers.
    Lei HP; Yu XY; Xie HT; Li HH; Fan L; Dai LL; Chen Y; Zhou HH
    Xenobiotica; 2010 Apr; 40(4):275-81. PubMed ID: 20102294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [St. John's wort: interaction with cyclosporine increases risk of rejection for the kidney transplant and raises daily cost of medication].
    Beer AM; Ostermann T
    Med Klin (Munich); 2001 Aug; 96(8):480-3. PubMed ID: 11560049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin.
    Sugimoto K; Ohmori M; Tsuruoka S; Nishiki K; Kawaguchi A; Harada K; Arakawa M; Sakamoto K; Masada M; Miyamori I; Fujimura A
    Clin Pharmacol Ther; 2001 Dec; 70(6):518-24. PubMed ID: 11753267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
    Jiang X; Williams KM; Liauw WS; Ammit AJ; Roufogalis BD; Duke CC; Day RO; McLachlan AJ
    Br J Clin Pharmacol; 2004 May; 57(5):592-9. PubMed ID: 15089812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of effect of St John's Wort on carbamazepine pharmacokinetics in healthy volunteers.
    Burstein AH; Horton RL; Dunn T; Alfaro RM; Piscitelli SC; Theodore W
    Clin Pharmacol Ther; 2000 Dec; 68(6):605-12. PubMed ID: 11180020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).
    Markowitz JS; DeVane CL
    Psychopharmacol Bull; 2001; 35(1):53-64. PubMed ID: 12397870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum).
    Johne A; Brockmöller J; Bauer S; Maurer A; Langheinrich M; Roots I
    Clin Pharmacol Ther; 1999 Oct; 66(4):338-45. PubMed ID: 10546917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic interactions of drugs with St John's wort.
    Zhou S; Chan E; Pan SQ; Huang M; Lee EJ
    J Psychopharmacol; 2004 Jun; 18(2):262-76. PubMed ID: 15260917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of St John's wort extract on heart rate variability, cognitive function and quantitative EEG: a comparison with amitriptyline and placebo in healthy men.
    Siepmann M; Krause S; Joraschky P; Mück-Weymann M; Kirch W
    Br J Clin Pharmacol; 2002 Sep; 54(3):277-82. PubMed ID: 12236848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
    Wang Z; Gorski JC; Hamman MA; Huang SM; Lesko LJ; Hall SD
    Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of St John's wort dose and preparations on the pharmacokinetics of digoxin.
    Mueller SC; Uehleke B; Woehling H; Petzsch M; Majcher-Peszynska J; Hehl EM; Sievers H; Frank B; Riethling AK; Drewelow B
    Clin Pharmacol Ther; 2004 Jun; 75(6):546-57. PubMed ID: 15179409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-administration of St. John's wort and hormonal contraceptives: a systematic review.
    Berry-Bibee EN; Kim MJ; Tepper NK; Riley HE; Curtis KM
    Contraception; 2016 Dec; 94(6):668-677. PubMed ID: 27444983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole.
    Wang LS; Zhou G; Zhu B; Wu J; Wang JG; Abd El-Aty AM; Li T; Liu J; Yang TL; Wang D; Zhong XY; Zhou HH
    Clin Pharmacol Ther; 2004 Mar; 75(3):191-7. PubMed ID: 15001970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug interactions with St John's wort : mechanisms and clinical implications.
    Mannel M
    Drug Saf; 2004; 27(11):773-97. PubMed ID: 15350151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.
    Barnes J; Anderson LA; Phillipson JD
    J Pharm Pharmacol; 2001 May; 53(5):583-600. PubMed ID: 11370698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.